![Mikael Widell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mikael Widell is the founder of Cord Communications, Inc. which was founded in 2015.
He holds the title of Partner at Cord Communications, Inc. Mr. Widell is currently the Director at Cordcom Consultants AB and the General Partner at Wz Kommunikation Kommanditbolag.
Mr. Widell's former positions include Head-Communications & Investor Relations at Calliditas Therapeutics AB, Vice President-Communications & Media Contact at Vivesto AB, and Head-Investor Relations & Communication at Ascelia Pharma AB. Mr. Widell received a graduate degree from the University of Lund.
| Unternehmen | Position | Beginn |
|---|---|---|
Cord Communications, Inc.
 Cord Communications, Inc. Engineering & ConstructionIndustrial Services Builder and owner of communications and broadcast towers | Gründer | 01.07.2015 |
Cordcom Consultants AB | Direktor/Vorstandsmitglied | - |
Wz Kommunikation Kommanditbolag | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Investor Relations Kontakt | - |
| ASCELIA PHARMA AB | Investor Relations Kontakt | - |
| VIVESTO AB | Public Communications Contact | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 7 |
|---|---|
Cord Communications, Inc.
Cord Communications, Inc. Engineering & ConstructionIndustrial Services Builder and owner of communications and broadcast towers | Industrial Services |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Cordcom Consultants AB | |
Wz Kommunikation Kommanditbolag |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
